Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Buffet-Bataillon, Sylvie; Tattevin, Pierre; Maillard, Jean-Yves; Bonnaure-Mallet, Martine; Jolivet-Gougeon, Anne (2016)
Publisher: Future Medicine
Languages: English
Types: Article
Subjects: RM
Biocides, primarily those containing quaternary ammonium compounds (QAC), are heavily used in hospital environments and various industries (e.g., food, water, cosmetic). To date, little attention has been paid to potential implications of QAC use in the emergence of antibiotic resistance, especially fluoroquinolone-resistant bacteria in patients and in the environment. QAC-induced overexpression of efflux pumps can lead to: cross resistance with fluoroquinolones mediated by multidrug efflux pumps; stress response facilitating mutation in the Quinolone Resistance Determining Region; and biofilm formation increasing the risk of transfer of mobile genetic elements carrying fluoroquinolone or QAC resistance determinants. By following the European Biocidal Product Regulation, manufacturers of QAC are required to ensure that their QAC-based biocidal products are safe and will not contribute to emerging bacterial resistance.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Gerba CP. Quaternary ammonium biocides: efficacy in application. Appl. Environ. Microbiol., 81(2), 464-469 (2015).  This article reports the uses of different QAC and the structure-activity relationship of these products, with evolution in their effectiveness and expansion of applications
    • 2. Merianos JJ. Quaternary ammonium antimicrobial compounds. In: Block SS, editor. Disinfection, sterilization, and preservation., 4th ed. Philadelphia, 225- 255 (1991).
    • 3. Walker EB. Quaternary ammonium compounds. In: Paulson D, editor. Handbook of topical antimicrobials: industrial applications in consumer products and pharmaceuticals, New York, NY: Marcel Dekker, 99-116 (2003).
    • 4. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J. Appl. Microbiol., 99(4), 703-715 (2005).
    • 5. Xue Y, Hieda Y, Kimura K, Takayama K, Fujihara J, Tsujino Y. Kinetic characteristics and toxic effects of benzalkonium chloride following intravascular and oral administration in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 811(1), 53-58 (2004).
    • 6. Clara M, Scharf S, Scheffknecht C, Gans O. Occurrence of selected surfactants in untreated and treated sewage. Water Res., 41(19), 4339-4348 (2007).
    • 7. Sutterlin H, Alexy R, Coker A, Kummerer K. Mixtures of quaternary ammonium compounds and anionic organic compounds in the aquatic environment: Elimination and biodegradability in the closed bottle test monitored by LCMS/MS. Chemosphere, 72(3), 479-484 (2008).
    • 8. Biocidal Product Regulation. http://eur-lex.europa.eu/legalcontent/EN/TXT/PDF/?uri=CELEX:02012R0528-20140425&from=EN. (accessed June 2015).
    • 9. SCENIHR 2009. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_021 .pdf (accessed June 2005).
    • 10. Maillard JY, Bloomfield S, Coelho JR et al. Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment. Microb. Drug. Resist., 19(5), 344-354 (2013).  This work makes specific recommendations for harmonization of key terms and refinement/standardization of methods for testing microbicide resistance to better assess the impact and possible links with cross resistance to antibiotics.
    • 11. Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1,8- Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents. J. Med. Pharm. Chem., 91, 1063-1065 (1962).
    • 12. Ball P. Quinolone generations: natural history or natural selection? J. Antimicrob. Chemother., 46 Suppl T1, 17-24 (2000).
    • 13. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis., 32 Suppl 1, S9-S15 (2001).
    • Pruss GJ, Franco RJ, Chevalier SG, Manes SH, Drlica K. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol., 168(1), 276-282 (1986).
    • Trends Genet., 6(12), 433-437 (1990).
    • Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin. Infect. Dis., 30(2), 243-254 (2000).
    • Int. J. Antimicrob. Agents, 40(3), 196-203 (2012).
    • Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev., 64(4), 672-693 (2000).
    • Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence, 4(3), 223-229 (2013).
    • Li XZ, Zhang L, Poole K. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother., 45(4), 433-436 (2000).
    • Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med, 39(3), 162-176 (2007).
    • Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother., 51(5), 1109-1117 (2003).
    • Laskaris P, Tolba S, Calvo-Bado L, Wellington EM. Coevolution of antibiotic production and counter-resistance in soil bacteria. Environ. Microbiol., 12(3), 783-796 (2010).
    • Tezel U, Pavlostathis SG. Quaternary ammonium disinfectants: microbial adaptation, degradation and ecology. Curr. Opin. Biotechnol., 33, 296-304 (2015).
    • Dis., 13(2), 155-165 (2013).
    • Collis CM, Hall RM. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Chemother., 39(1), 155-162 (1995).
    • Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis., 33(8), 1288-1294 (2001).
    • Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA, 289(7), 885-888 (2003).
    • WHO. Critically important antimicrobials for human medicine. 3rd revision, 2011, http://www.who.int/foodborne_disease/resistance/cia/ en (accessed Nov 1st, 2013). Kumar S, Mukherjee MM, Varela MF. Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily. Int. J. Bacteriol., 2013 (2013). Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front. Microbiol., 6, 377 (2015).
    •  These data described the methodologies for measuring efflux pump inhibition, could allow the design, and subsequent experimental verification of potential efflux pump inhibitors (EPIs). They explored new compounds that could reverse drug resistance in Gram-negative pathogens. Wassenaar TM, Ussery D, Nielsen LN, Ingmer H. Review and phylogenetic analysis of qac genes that reduce susceptibility to quaternary ammonium compounds in Staphylococcus species. Eur. J. Microbiol. Immunol. (Bp), 5(1), 44-61 (2015).
    •  The aim of this study was to list the qac genes in staphylococci, belonging to Major Facilitator Superfamily (MFS) and Small Multidrug Resistance (SMR) families. Despite their resemblance in substrate specificity, the Qac proteins have little in common, and a number of phylogenetic trees of SMR Qac proteins are presented. Buffet-Bataillon S, Le Jeune A, Le Gall-David S, Bonnaure-Mallet M, JolivetGougeon A. Molecular mechanisms of higher MICs of antibiotics and quaternary ammonium compounds for Escherichia coli isolated from bacteraemia. J. Antimicrob. Chemother., 67(12), 2837-2842 (2012).
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.

Share - Bookmark

Cite this article